40641-71-2

Basic information

• Product Name: 4'-Bromobiphenyl-3-amine
• Synonyms: 4'-Bromobiphenyl-3-amine;4'-Bromo-biphenyl-3-ylamine
• CAS NO: 40641-71-2
• Molecular Formula: C₁₂H₁₀BrN
• Molecular Weight: 248.12
• Mol File: 40641-71-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4'-Bromobiphenyl-3-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 4'-Bromobiphenyl-3-amine(40641-71-2)
• EPA Substance Registry System: 4'-Bromobiphenyl-3-amine(40641-71-2)

Safety Data

• Hazardous Substances Data: 40641-71-2(Hazardous Substances Data)

Upstream product

• 32858-99-4 4’-bromo-3-nitrobiphenyl 
• 5467-74-3 4-Bromophenylboronic acid 
• 626-01-7 3-Iodoaniline 
• 106-37-6 1.4-dibromobenzene 
• 30418-59-8 3-Aminophenylboronic acid 
• 2113-58-8 3-nitro-1,1'-biphenyl 

Downstream Products

• 874499-34-0 7-(4-bromo-phenyl)-quinolin-4-ol 
• 860719-81-9 7-(4-bromo-phenyl)-4-chloro-quinoline 
• 872789-98-5 7-(4-bromo-phenyl)-4-hydroxy-quinoline-2-carboxylic acid 
• 130201-29-5 3,3'''-Bis<<1-(biphenyl-3-yl)-2-methyl-1-propenyl>>-p-quaterphenyl 
• 130201-23-9 1,1-Bis(4'-brombiphenyl-3-yl)-2-propyl-1-pentanol 
• 130201-28-4 2,2-Bis(4'-brombiphenyl-3-yl)-1,3-dioxan 
• 130201-25-1 1,1-Bis(4'-brombiphenyl-3-yl)-2-propyl-1-penten 
• 130201-22-8 1,1-Bis(4'-brombiphenyl-3-yl)-2-methyl-1-propanol 
• 130201-26-2 Bis(4'-brombiphenyl-3-yl)methanol 
• 130201-24-0 1,1-Bis(4'-brombiphenyl-3-yl)-2-methyl-1-propen 
• 130201-27-3 3,3'-Bis(4-brombiphenyl)benzophenon 
• 586-76-5 4-Bromobenzoic acid 
• 130201-21-7 4’-bromo-3-iodo-1,1’-biphenyl 
• 91354-09-5 4-bromo-3'-chloro-1,1'-biphenyl 

Relevant articles and documents

ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE

The application is directed to compounds of formulae (IA) and (IB): (IA) and (IB), and their salts and solvates, wherein R1a, R2a, A1, A2, A3, A4, R1b, R2b, B1, B2, B3, and G are as set forth in the specification, as well as to methods for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of, e.g., lysosomal storage diseases, such as Krabbe's disease, and α-synucleinopathies, such as Parkinson's disease.

LINCOMYCIN DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT

This invention provides compounds of formula (I) or its pharmacologically acceptable salt or solvate, wherein A represents aryl or a monocyclic or bicyclic heterocyclic group, R1 represents a halide, nitro, substituted C1-6 alkyl, optionally substituted amino, C1-6 alkyloxycarbonyl, optionally substituted aryl, a heterocyclic group, or heterocyclic carbonyl, R2 represents a hydrogen atom or C1-6 alkyl, R3 represents C1-6 alkyl, all of R4, R5, and R6 represent a hydrogen atom, R7 represents C1-6 alkyl, m is 1 or 2, and n is 1. The compounds are novel lincomycin derivatives having a potent activity against resistant pneumococci. The compounds can be used as an antimicrobial agent and are useful for preventing or treating bacterial infectious diseases.